DIAGNOS (CVE:ADK) Trading Down 1.8%

DIAGNOS Inc. (CVE:ADK) shares dropped 1.8% during mid-day trading on Tuesday . The company traded as low as C$0.27 and last traded at C$0.28. Approximately 36,000 shares changed hands during trading, a decline of 57% from the average daily volume of 83,932 shares. The stock had previously closed at C$0.28.

DIAGNOS Price Performance

The stock’s 50 day moving average price is C$0.28 and its 200-day moving average price is C$0.36. The company has a quick ratio of 0.68, a current ratio of 0.70 and a debt-to-equity ratio of 245.28. The stock has a market capitalization of C$21.08 million, a PE ratio of -6.88 and a beta of -0.40.

DIAGNOS (CVE:ADK) last released its quarterly earnings data on Wednesday, February 28th. The company reported C($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of C($0.01). The company had revenue of C$0.05 million during the quarter, compared to analysts’ expectations of C$0.10 million. As a group, equities analysts forecast that DIAGNOS Inc. will post -0.02 EPS for the current year.

Insider Transactions at DIAGNOS

In related news, insider Tristram Coffin sold 800,000 shares of DIAGNOS stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of C$0.30, for a total value of C$240,000.00. Corporate insiders own 14.23% of the company’s stock.

About DIAGNOS

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.